MedTrace Logo

Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer

NCT04775043 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2022-08-29

No results posted yet for this study

Summary

The validation of the HFRDIS questionnaire in French will allow the use in common practice of this questionnaire in consultation in order to have a concrete and reproducible assessment of the impact of hot flashes on the daily life of patients. This validation will also allow this questionnaire to be used in therapeutic trials to assess the effectiveness of a symptomatic treatment under study.

The use of this questionnaire in patients on hormone therapy will allow for an overall assessment of the impact of hot flashes in their daily lives.

There are no risks induced by participation in this research, it is only an observational study without change on the monitoring of participants in both cohorts.

Conditions

Interventions

DIAGNOSTIC_TEST

HFRDIS questionnaire completion

HFRDIS Questionnaire (Hot Flash Related Daily Interference Scale) completion

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • Delphine HEQUET, Dr · Institut Curie Saint-Cloud

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-23
Primary Completion
2022-04-11
Completion
2022-04-11

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04775043 on ClinicalTrials.gov